Thomas D Lei, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 6 carriers
- Offices
- 3
Offices
3 locations · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
22 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lei’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78558 · Current
Licensed to practise in California · since 2002 · expires 2027-09-30 · The Third Military Medical University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$178,662
Medicare paid this office $178,662 for 328 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 240 | $58,336 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $42,384 | $99 |
| Critical care, first 30-74 minutes | 23 | $18,834 | $173 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $11,213 | $138 |
| New patient visit (45+ min) | 63 | $8,428 | $134 |
See all 24 services
| Return visit (30+ min) | 240 | $58,336 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $42,384 | $99 |
| Critical care, first 30-74 minutes | 23 | $18,834 | $173 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $11,213 | $138 |
| New patient visit (45+ min) | 63 | $8,428 | $134 |
| Evaluation of use of breathing device | 151 | $6,105 | $18 |
| Ct scan of chest without contrast | 100 | $4,956 | $43 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 28 | $3,706 | $128 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 83 | $3,164 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,035 | $108 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 29 | $2,305 | $77 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 12 | $2,168 | $167 |
| Ct scan of chest with contrast | 43 | $1,977 | $45 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 18 | $1,779 | $99 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 79 | $1,670 | $20 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 29 | $1,611 | $54 |
| Placement of radiation therapy markers into lung airways using an endoscope | 18 | $1,426 | $79 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 29 | $936 | $31 |
| Ct scan of chest without contrast | 21 | $899 | $43 |
| X-ray of chest, 2 views | 57 | $535 | $9 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 12 | $495 | $41 |
| Imaging guidance for procedure, 60 minutes or less | 29 | $365 | $12 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 11 | $258 | $16 |
| X-ray of chest, 2 views | 25 | $219 | $9 |
Who their Medicare patients are
328 Original Medicare patients in 2024. Average age 79 · Under 65 5% · 85 and older 29% · Women 49% · Also on Medicaid 76% · Health risk score 2.16. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · COPD 63% · Diabetes 55% · Chronic kidney disease 40% · Coronary heart disease 37% · Heart failure 33% · Atrial fibrillation 28% · Dementia 18% · Cancer 17% · Depression 13% · Stroke 9%.
The office billed $349,242, Medicare allowed $235,079 and paid $178,662; for 2,353 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 328 | 2,353 | 79 | 2.16 | $349,242 | $178,662 |
| 2023 | 364 | 2,748 | 79 | 1.96 | $407,753 | $232,979 |
| 2022 | 359 | 2,860 | 79 | 2.23 | $409,509 | $224,102 |
| 2021 | 398 | 2,709 | 78 | 2.18 | $391,637 | $230,143 |
| 2020 | 521 | 4,676 | 78 | 2.60 | $668,766 | $443,543 |
| 2019 | 648 | 5,104 | 78 | 2.40 | $777,918 | $416,141 |
| 2018 | 551 | 4,529 | 78 | 2.67 | $558,423 | $350,168 |
| 2017 | 505 | 4,200 | 78 | 2.24 | $535,269 | $330,451 |
| 2016 | 419 | 3,459 | 77 | 2.37 | $446,246 | $292,929 |
| 2015 | 406 | 3,435 | 77 | 2.34 | $431,679 | $290,614 |
| 2014 | 510 | 4,001 | 77 | 2.33 | $474,374 | $323,431 |
| 2013 | 610 | 6,319 | 78 | 2.50 | $811,818 | $559,433 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $82,140 | $107 |
| Return visit (30+ min) | 241 | $58,773 | $107 |
| Critical care, first 30-74 minutes | 26 | $22,742 | $188 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 104 | $18,596 | $156 |
| New patient visit (45+ min) | 70 | $10,409 | $149 |
| Evaluation of use of breathing device | 159 | $6,318 | $19 |
| Ct scan of chest without contrast | 83 | $4,724 | $47 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 91 | $3,785 | $40 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 24 | $3,180 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,454 | $117 |
| Ct scan of chest with contrast | 47 | $2,378 | $51 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 92 | $2,102 | $22 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 24 | $1,992 | $83 |
| Ct scan of chest without contrast | 32 | $1,497 | $47 |
| Placement of radiation therapy markers into lung airways using an endoscope | 17 | $1,450 | $85 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 15 | $1,446 | $96 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 23 | $1,331 | $58 |
| X-ray of chest, 2 views | 76 | $801 | $10 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 24 | $758 | $32 |
| Ct scan of chest with contrast | 11 | $557 | $51 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 16 | $555 | $35 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $315 | $14 |
| X-ray of chest, 2 views | 28 | $266 | $10 |
| Test to determine lung volumes using sensors | 14 | $150 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $128 | $9 |
| Test to examine how well the lungs exchange gases | 14 | $111 | $8 |
| Exam of lung airways using an endoscope | 13 | $7 | $1 |
2022: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $80,288 | $92 |
| Return visit (30+ min) | 228 | $53,785 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $25,434 | $175 |
| Critical care, first 30-74 minutes | 24 | $21,932 | $192 |
| Evaluation of use of breathing device | 154 | $6,822 | $17 |
| New patient visit (45+ min) | 38 | $4,714 | $124 |
| Ct scan of chest without contrast | 75 | $3,758 | $47 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 68 | $3,004 | $41 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 19 | $2,852 | $150 |
| Initial hospital observation care per day, typically 50 minutes | 20 | $2,388 | $119 |
| Ct scan of chest with contrast | 44 | $2,347 | $51 |
| Ct scan of chest without contrast | 40 | $1,951 | $48 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 19 | $1,629 | $86 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 67 | $1,629 | $22 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 14 | $1,392 | $99 |
| Placement of radiation therapy markers into lung airways using an endoscope | 11 | $964 | $88 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 15 | $898 | $60 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 21 | $882 | $42 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 20 | $848 | $42 |
| X-ray of chest, 2 views | 72 | $812 | $10 |
| X-ray of chest, 2 views | 30 | $292 | $9 |
| Imaging guidance for procedure, 60 minutes or less | 20 | $273 | $14 |
| Exam of lung airways using an endoscope | 13 | $17 | $1 |
2021: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $69,617 | $94 |
| Return visit (30+ min) | 261 | $62,153 | $104 |
| Critical care, first 30-74 minutes | 26 | $26,232 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $26,000 | $183 |
| New patient visit (45+ min) | 60 | $9,021 | $150 |
| Evaluation of use of breathing device | 165 | $6,093 | $18 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 96 | $5,105 | $49 |
| Ct scan of chest without contrast | 85 | $4,526 | $48 |
| Ct scan of chest with contrast | 50 | $2,686 | $53 |
| Ct scan of chest without contrast | 50 | $2,580 | $49 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 96 | $2,378 | $23 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 11 | $2,050 | $171 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,591 | $122 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 12 | $1,317 | $110 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 11 | $1,049 | $87 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 13 | $741 | $53 |
| X-ray of chest, 2 views | 63 | $726 | $10 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 12 | $694 | $58 |
| Ct scan of chest with contrast | 11 | $632 | $53 |
| X-ray of chest, 2 views | 31 | $328 | $10 |
| Exam of lung airways using an endoscope | 11 | $19 | $2 |
2020: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 247 | $228,727 | $96 |
| Critical care, first 30-74 minutes | 44 | $65,130 | $200 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 234 | $53,253 | $185 |
| Return visit (30+ min) | 270 | $46,216 | $96 |
| New patient visit (45+ min) | 59 | $8,820 | $149 |
| Evaluation of use of breathing device | 187 | $5,667 | $17 |
| Ct scan of chest without contrast | 90 | $5,018 | $53 |
| Ct scan of chest with contrast | 77 | $4,566 | $58 |
| Ct scan of chest without contrast | 76 | $4,183 | $54 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 45 | $2,801 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,574 | $66 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 14 | $2,141 | $153 |
| X-ray of chest, 2 views | 131 | $1,660 | $10 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 25 | $1,108 | $44 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 44 | $1,052 | $23 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 12 | $741 | $62 |
| X-ray of chest, 2 views | 45 | $476 | $10 |
| Exam of lung airways using an endoscope | 20 | $91 | $5 |
2019: 28 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 256 | $151,725 | $89 |
| Return visit (30+ min) | 362 | $75,272 | $94 |
| Critical care, first 30-74 minutes | 57 | $50,022 | $187 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 203 | $40,175 | $172 |
| New patient visit (45+ min) | 161 | $22,799 | $142 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 171 | $10,455 | $59 |
| Ct scan of chest without contrast | 154 | $8,945 | $50 |
| Evaluation of use of breathing device | 246 | $8,898 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $5,121 | $62 |
| Initial hospital observation care per day, typically 50 minutes | 37 | $4,546 | $117 |
| Ct scan of chest without contrast | 81 | $4,302 | $51 |
| Ct scan of chest with contrast | 75 | $4,109 | $54 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 177 | $4,066 | $22 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 24 | $3,550 | $142 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 24 | $2,963 | $119 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 44 | $2,409 | $49 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 23 | $1,990 | $83 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 27 | $1,301 | $46 |
| X-ray of chest, 2 views | 105 | $1,113 | $10 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 18 | $1,099 | $58 |
| Ct scan of chest with contrast | 18 | $973 | $54 |
| Placement of radiation therapy markers into lung airways using an endoscope | 11 | $906 | $82 |
| X-ray of chest, 2 views | 86 | $903 | $9 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 19 | $647 | $31 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 16 | $427 | $16 |
| Inhalation treatment for airway obstruction or sputum production | 14 | $277 | $18 |
| Exam of lung airways using an endoscope | 29 | $210 | $7 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $171 | $13 |
2018: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 217 | $115,940 | $88 |
| Return visit (30+ min) | 325 | $76,934 | $91 |
| Critical care, first 30-74 minutes | 55 | $44,819 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 134 | $26,784 | $171 |
| New patient visit (45+ min) | 118 | $15,914 | $135 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 227 | $15,702 | $58 |
| Evaluation of use of breathing device | 233 | $8,445 | $17 |
| Ct scan of chest without contrast | 143 | $8,376 | $49 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 229 | $5,864 | $22 |
| Ct scan of chest without contrast | 75 | $3,915 | $50 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 22 | $3,433 | $143 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 18 | $2,776 | $139 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 22 | $2,723 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $2,583 | $62 |
| Ct scan of chest with contrast | 45 | $2,435 | $53 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 18 | $1,625 | $81 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 34 | $1,315 | $37 |
| X-ray of chest, 2 views | 91 | $912 | $9 |
| X-ray of chest, 2 views | 78 | $782 | $9 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 17 | $672 | $37 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 14 | $505 | $30 |
| Inhalation treatment for airway obstruction or sputum production | 12 | $207 | $17 |
| Exam of lung airways using an endoscope | 26 | $126 | $5 |
2017: 29 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 211 | $108,775 | $87 |
| Return visit (30+ min) | 296 | $70,554 | $93 |
| Critical care, first 30-74 minutes | 55 | $35,105 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $27,348 | $168 |
| New patient visit (45+ min) | 80 | $10,821 | $135 |
| New patient visit (60+ min) | 57 | $9,982 | $175 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 157 | $9,872 | $58 |
| Evaluation of use of breathing device | 205 | $7,990 | $17 |
| Ct scan of chest without contrast | 107 | $5,347 | $43 |
| Critical care, each additional 30 minutes | 24 | $5,225 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $4,647 | $60 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 26 | $4,513 | $141 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 159 | $3,740 | $21 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 22 | $3,621 | $151 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 23 | $3,072 | $118 |
| Ct scan of chest without contrast | 56 | $2,501 | $43 |
| Ct scan of chest with contrast | 40 | $2,213 | $53 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 23 | $1,788 | $62 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 19 | $1,777 | $81 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 35 | $1,650 | $42 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 18 | $705 | $29 |
| X-ray of chest, 2 views, front and side | 70 | $672 | $9 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 17 | $602 | $15 |
| X-ray of chest, 2 views, front and side | 51 | $543 | $9 |
| Biopsy of lung airway using an endoscope | 12 | $512 | $43 |
| Administration of influenza virus vaccine | 14 | $452 | $32 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $309 | $18 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Exam of lung airways using an endoscope | 23 | $186 | $7 |
2016: 27 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $88,109 | $91 |
| Return visit (30+ min) | 237 | $60,094 | $96 |
| Critical care, first 30-74 minutes | 45 | $37,203 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $27,697 | $174 |
| New patient visit (60+ min) | 72 | $13,255 | $184 |
| Critical care, each additional 30 minutes | 33 | $9,812 | $96 |
| Evaluation of use of breathing device | 173 | $7,084 | $18 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 105 | $6,772 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $6,616 | $63 |
| Ct scan of chest without contrast | 70 | $3,352 | $45 |
| Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day at least 70 minutes | 15 | $2,801 | $147 |
| New patient visit (45+ min) | 19 | $2,728 | $144 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 14 | $2,718 | $170 |
| Removal of fluid from between lung and chest cavity | 15 | $2,615 | $145 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 108 | $2,607 | $22 |
| Ct scan of chest with contrast | 42 | $2,490 | $55 |
| Ct scan of chest without contrast | 47 | $2,174 | $45 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 24 | $2,152 | $74 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 13 | $1,268 | $85 |
| X-ray of chest, 2 views, front and side | 72 | $811 | $10 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 15 | $805 | $47 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 14 | $472 | $31 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 12 | $407 | $27 |
| X-ray of chest, 2 views, front and side | 39 | $406 | $10 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 12 | $293 | $13 |
| Inhalation treatment for airway obstruction or sputum production | 11 | $228 | $19 |
| Exam of lung airways using an endoscope | 14 | $47 | $3 |
2015: 20 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 167 | $89,146 | $92 |
| Return visit (30+ min) | 238 | $61,461 | $97 |
| Critical care, first 30-74 minutes | 44 | $41,560 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $25,189 | $177 |
| Critical care, each additional 30 minutes | 35 | $14,898 | $97 |
| New patient visit (60+ min) | 63 | $11,552 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $7,392 | $64 |
| Evaluation of use of breathing device | 178 | $7,157 | $18 |
| Ct scan of chest without contrast | 91 | $4,710 | $45 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | $4,094 | $60 |
| Ct scan of chest with contrast | 50 | $2,890 | $56 |
| Ct scan of chest without contrast | 41 | $1,998 | $45 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 63 | $1,514 | $23 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 18 | $1,218 | $64 |
| X-ray of chest, 2 views, front and side | 78 | $923 | $10 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 11 | $830 | $75 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 19 | $657 | $24 |
| X-ray of chest, 2 views, front and side | 48 | $515 | $9 |
| Inhalation treatment for airway obstruction or sputum production | 16 | $402 | $19 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 11 | $317 | $13 |
2014: 23 services
| Return visit (30+ min) | 313 | $89,840 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $75,322 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 144 | $32,261 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $26,261 | $64 |
| Critical care, first 30-74 minutes | 44 | $22,479 | $195 |
| New patient visit (60+ min) | 114 | $20,807 | $183 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 122 | $7,821 | $61 |
| Critical care, each additional 30 minutes | 40 | $7,628 | $98 |
| Evaluation of use of breathing device | 208 | $7,472 | $18 |
| Ct scan of chest without contrast | 100 | $5,520 | $46 |
| Ct scan of chest without contrast | 67 | $3,422 | $46 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 14 | $3,092 | $193 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 129 | $3,069 | $23 |
| Removal of fluid from between lung and chest cavity | 11 | $2,283 | $152 |
| Ct scan of chest with contrast | 30 | $1,735 | $56 |
| X-ray of chest, 2 views, front and side | 97 | $1,112 | $10 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 12 | $1,022 | $85 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 13 | $963 | $74 |
| X-ray of chest, 2 views, front and side | 87 | $945 | $10 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 17 | $567 | $25 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 15 | $381 | $13 |
| Inhalation treatment for airway obstruction or sputum production | 15 | $304 | $19 |
| Exam of lung airways using an endoscope | 13 | $15 | $1 |
2013: 34 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 317 | $160,376 | $90 |
| Critical care, first 30-74 minutes | 116 | $89,456 | $192 |
| Return visit (30+ min) | 285 | $82,239 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 233 | $50,245 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $49,245 | $62 |
| New patient visit (60+ min) | 175 | $32,006 | $183 |
| Critical care, each additional 30 minutes | 99 | $21,949 | $96 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 143 | $10,080 | $65 |
| Evaluation of use of breathing device | 214 | $6,870 | $19 |
| Removal of fluid from between lung and chest cavity | 35 | $6,027 | $151 |
| Ct scan of chest without contrast | 92 | $4,390 | $43 |
| Aspiration of initial secretion of lung airway using an endoscope | 21 | $4,263 | $142 |
| Ct scan of chest with contrast | 76 | $4,162 | $53 |
| Ct scan of chest without contrast | 73 | $3,441 | $43 |
| Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | 139 | $3,174 | $21 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 15 | $3,001 | $188 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 24 | $2,609 | $104 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 27 | $2,084 | $69 |
| X-ray of chest, 2 views, front and side | 156 | $1,887 | $9 |
| New patient visit (45+ min) | 12 | $1,788 | $149 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 15 | $1,772 | $93 |
| Administration of influenza virus vaccine | 49 | $1,574 | $32 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 16 | $1,550 | $97 |
| Ct scan of chest with contrast | 22 | $1,172 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $1,015 | $34 |
| Pneumococcal vaccine, 23-valent | 14 | $967 | $69 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 23 | $725 | $24 |
| X-ray of chest, 2 views, front and side | 63 | $636 | $9 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 49 | $578 | $12 |
| Inhalation treatment for airway obstruction or sputum production | 20 | $487 | $20 |
| Administration of pneumococcal vaccine | 14 | $453 | $32 |
| Test to measure expiratory airflow and volume | 11 | $414 | $38 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $256 | $13 |
| Exam of lung airways using an endoscope | 16 | $23 | $1 |
Medicaid work
$130 in 2024
Medicaid paid $130 for 158 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| 1ST HOSP IP/OBS HIGH 75 | 12 | $88 |
| Return visit (30+ min) | 75 | $41 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 71 | $0 |
| 2024 | 158 | 3 | 18 | $130 |
| 2023 | 1,189 | 8 | 53 | $1,876 |
| 2022 | 1,228 | 7 | 56 | $3,336 |
| 2021 | 1,334 | 8 | 46 | $905 |
| 2020 | 2,123 | 10 | 58 | $3,927 |
| 2019 | 1,336 | 8 | 38 | $3,178 |
| 2018 | 838 | 8 | 56 | $1,534 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 345 | $1,237 |
| Return visit (30+ min) | 438 | $250 |
| 1ST HOSP IP/OBS HIGH 75 | 28 | $240 |
| EVALUATION OF WHEEZING | 71 | $91 |
| Radiologic examination, chest; 2 views | 65 | $24 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 185 | $21 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 45 | $13 |
| New patient visit (45+ min) | 12 | $0 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 318 | $2,107 |
| Return visit (30+ min) | 549 | $1,098 |
| EVALUATION OF WHEEZING | 46 | $61 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 232 | $31 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 43 | $26 |
| Radiologic examination, chest; 2 views | 28 | $13 |
| New patient visit (45+ min) | 12 | $0 |
2021
| Return visit (30+ min) | 474 | $503 |
| 1ST HOSP IP/OBS HIGH 75 | 27 | $229 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 370 | $118 |
| EVALUATION OF WHEEZING | 89 | $30 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 77 | $18 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 261 | $9 |
| Radiologic examination, chest; 2 views | 12 | $0 |
| New patient visit (45+ min) | 24 | $0 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,207 | $2,728 |
| Return visit (30+ min) | 350 | $515 |
| 1ST HOSP IP/OBS HIGH 75 | 108 | $493 |
| Computed tomography, thorax, diagnostic; without contrast material | 26 | $119 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 242 | $59 |
| Radiologic examination, chest; 2 views | 84 | $12 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 13 | $1 |
| EVALUATION OF WHEEZING | 13 | $0 |
| MEASURE BLOOD OXYGEN LEVEL | 66 | $0 |
| New patient visit (45+ min) | 14 | $0 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 222 | $2,555 |
| Return visit (30+ min) | 286 | $398 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 171 | $97 |
| EVALUATION OF WHEEZING | 181 | $61 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 131 | $28 |
| Radiologic examination, chest; 2 views | 63 | $28 |
| New patient visit (45+ min) | 95 | $13 |
| MEASURE BLOOD OXYGEN LEVEL | 187 | $0 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 96 | $759 |
| Return visit (30+ min) | 306 | $556 |
| EVALUATION OF WHEEZING | 93 | $105 |
| Computed tomography, thorax, diagnostic; without contrast material | 14 | $48 |
| Patient-initiated spirometric recording per 30-day period of time; review and interpretation only by a physician or other qualified health care professional | 82 | $42 |
| New patient visit (45+ min) | 12 | $26 |
| Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device | 127 | $0 |
| MEASURE BLOOD OXYGEN LEVEL | 108 | $0 |
Drugs they prescribed that Part D paid
$761,897
Pharmacies billed $761,897 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,849) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
274 generic and 1,575 brand-name prescriptions · $761,897 in drug cost · 37 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 631 | $487,206 | $772 |
| Breo Ellipta | 191 | $82,955 | $434 |
| Arnuity Ellipta | 223 | $56,357 | $253 |
| Incruse Ellipta | 87 | $30,790 | $354 |
| Combivent Respimat | 32 | $17,316 | $541 |
See all 22 drugs
| Trelegy Ellipta | 631 | $487,206 | $772 |
| Breo Ellipta | 191 | $82,955 | $434 |
| Arnuity Ellipta | 223 | $56,357 | $253 |
| Incruse Ellipta | 87 | $30,790 | $354 |
| Combivent Respimat | 32 | $17,316 | $541 |
| Spiriva Respimat | 20 | $16,033 | $802 |
| Qvar Redihaler | 33 | $11,087 | $336 |
| Breztri Aerosphere | 14 | $8,343 | $596 |
| Albuterol Sulfate Hfa | 237 | $7,215 | $30 |
| Fluticasone-Vilanterol | 14 | $5,300 | $379 |
| Atrovent Hfa | 12 | $5,194 | $433 |
| Ventolin Hfa | 83 | $4,479 | $54 |
| Fluticasone-Salmeterol | 18 | $3,396 | $189 |
| Wixela Inhub | 15 | $2,243 | $150 |
| Megestrol Acetate | 14 | $1,812 | $129 |
| Rifampin | 18 | $607 | $34 |
| Ethambutol | 19 | $595 | $31 |
| Azithromycin | 25 | $336 | $13 |
| Montelukast | 26 | $247 | $9 |
| Prednisone | 44 | $135 | $3 |
| Fluticasone Propionate | 11 | $130 | $12 |
| Omeprazole | 12 | $85 | $7 |
Year by year
| 2024 | 1,849 | 323 | 0% (0) | 85% | $761,897 |
| 2023 | 1,771 | 296 | 0% (0) | 88% | $859,197 |
| 2022 | 1,813 | 294 | 0% (0) | 85% | $899,582 |
| 2021 | 1,919 | 313 | 0% (0) | 88% | $906,551 |
| 2020 | 2,263 | 324 | 0% (0) | 92% | $969,229 |
| 2019 | 2,499 | 402 | 0% (0) | 92% | $918,773 |
| 2018 | 2,219 | 330 | 0% (0) | 88% | $710,106 |
| 2017 | 1,828 | 240 | 0% (0) | 81% | $484,528 |
| 2016 | 1,648 | 210 | 0% (0) | 82% | $406,474 |
| 2015 | 1,730 | 210 | 0% (0) | 82% | $411,779 |
| 2014 | 2,451 | 263 | None | 75% | $516,508 |
| 2013 | 2,013 | 251 | 0% (0) | 71% | $375,201 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Trelegy Ellipta | 604 | $502,563 | $832 |
| Breo Ellipta | 212 | $100,547 | $474 |
| Arnuity Ellipta | 160 | $44,004 | $275 |
| Incruse Ellipta | 80 | $32,900 | $411 |
| Symbicort | 40 | $28,689 | $717 |
| Combivent Respimat | 48 | $24,500 | $510 |
| Advair Diskus | 24 | $16,617 | $692 |
| Spiriva Handihaler | 16 | $14,073 | $880 |
| Spiriva Respimat | 25 | $13,619 | $545 |
| Flovent Hfa | 21 | $10,903 | $519 |
| Breztri Aerosphere | 14 | $9,399 | $671 |
| Qvar Redihaler | 29 | $8,203 | $283 |
| Ventolin Hfa | 104 | $6,814 | $66 |
| Atrovent Hfa | 12 | $5,933 | $494 |
| Albuterol Sulfate Hfa | 142 | $5,040 | $35 |
| Flovent Diskus | 16 | $4,809 | $301 |
| Pulmicort Flexhaler | 19 | $4,781 | $252 |
| Megestrol Acetate | 20 | $3,197 | $160 |
| Fluticasone-Salmeterol | 11 | $1,762 | $160 |
| Rifampin | 11 | $979 | $89 |
| Montelukast | 21 | $401 | $19 |
| Pantoprazole | 15 | $330 | $22 |
| Prednisone | 42 | $237 | $6 |
| Isoniazid | 11 | $131 | $12 |
2022: 23 drugs
| Trelegy Ellipta | 589 | $494,907 | $840 |
| Breo Ellipta | 193 | $103,071 | $534 |
| Incruse Ellipta | 96 | $40,092 | $418 |
| Symbicort | 61 | $39,537 | $648 |
| Arnuity Ellipta | 154 | $39,020 | $253 |
| Spiriva Respimat | 60 | $35,420 | $590 |
| Combivent Respimat | 43 | $23,005 | $535 |
| Spiriva Handihaler | 23 | $21,007 | $913 |
| Advair Diskus | 19 | $15,760 | $829 |
| Flovent Hfa | 27 | $14,743 | $546 |
| Voriconazole | 12 | $9,947 | $829 |
| Megestrol Acetate | 39 | $9,723 | $249 |
| Pulmicort Flexhaler | 29 | $9,480 | $327 |
| Qvar Redihaler | 36 | $8,835 | $245 |
| Albuterol Sulfate Hfa | 182 | $8,203 | $45 |
| Atrovent Hfa | 11 | $5,291 | $481 |
| Fluticasone-Salmeterol | 23 | $3,320 | $144 |
| Ventolin Hfa | 46 | $2,786 | $61 |
| Amoxicillin-Clavulanate Potass | 11 | $376 | $34 |
| Prednisone | 49 | $264 | $5 |
| Montelukast | 14 | $256 | $18 |
| Azithromycin | 17 | $229 | $13 |
| Omeprazole | 16 | $167 | $10 |
2021: 28 drugs
| Trelegy Ellipta | 577 | $445,089 | $771 |
| Breo Ellipta | 245 | $116,700 | $476 |
| Symbicort | 86 | $56,188 | $653 |
| Spiriva Respimat | 101 | $54,238 | $537 |
| Incruse Ellipta | 89 | $36,838 | $414 |
| Arnuity Ellipta | 107 | $27,895 | $261 |
| Combivent Respimat | 41 | $23,104 | $564 |
| Spiriva | 23 | $17,966 | $781 |
| Flovent Hfa | 44 | $17,496 | $398 |
| Pulmicort Flexhaler | 41 | $16,864 | $411 |
| Advair Diskus | 21 | $13,802 | $657 |
| Advair Hfa | 21 | $13,796 | $657 |
| Qvar Redihaler | 47 | $12,816 | $273 |
| Anoro Ellipta | 22 | $9,718 | $442 |
| Fluticasone-Salmeterol | 35 | $7,398 | $211 |
| Flovent Diskus | 14 | $6,226 | $445 |
| Albuterol Sulfate Hfa | 137 | $6,137 | $45 |
| Atrovent Hfa | 12 | $5,492 | $458 |
| Wixela Inhub | 13 | $3,693 | $284 |
| Ventolin Hfa | 59 | $3,535 | $60 |
| Rifampin | 19 | $1,726 | $91 |
| Megestrol Acetate | 13 | $1,183 | $91 |
| Ethambutol | 18 | $1,003 | $56 |
| Azithromycin | 27 | $926 | $34 |
| Pantoprazole | 11 | $234 | $21 |
| Prednisone | 38 | $214 | $6 |
| Montelukast | 12 | $199 | $17 |
| Omeprazole | 17 | $167 | $10 |
2020: 25 drugs
| Trelegy Ellipta | 603 | $395,762 | $656 |
| Breo Ellipta | 305 | $136,250 | $447 |
| Spiriva Respimat | 214 | $106,144 | $496 |
| Incruse Ellipta | 141 | $54,930 | $390 |
| Symbicort | 77 | $41,345 | $537 |
| Flovent Hfa | 92 | $34,965 | $380 |
| Combivent Respimat | 51 | $34,710 | $681 |
| Spiriva | 27 | $24,107 | $893 |
| Arnuity Ellipta | 71 | $17,170 | $242 |
| Pulmicort Flexhaler | 48 | $15,562 | $324 |
| Advair Diskus | 29 | $15,530 | $536 |
| Advair Hfa | 24 | $15,404 | $642 |
| Fluticasone-Salmeterol | 72 | $13,970 | $194 |
| Anoro Ellipta | 32 | $13,918 | $435 |
| Qvar Redihaler | 47 | $12,350 | $263 |
| Flovent Diskus | 25 | $10,559 | $422 |
| Ventolin Hfa | 123 | $7,078 | $58 |
| Wixela Inhub | 19 | $5,146 | $271 |
| Albuterol Sulfate Hfa | 67 | $2,965 | $44 |
| Megestrol Acetate | 29 | $1,307 | $45 |
| Proair Respiclick | 18 | $1,078 | $60 |
| Prednisone | 62 | $336 | $5 |
| Pantoprazole | 11 | $225 | $20 |
| Azithromycin | 14 | $191 | $14 |
| Omeprazole | 16 | $184 | $11 |
2019: 25 drugs
| Trelegy Ellipta | 597 | $342,835 | $574 |
| Breo Ellipta | 311 | $123,289 | $396 |
| Spiriva Respimat | 174 | $79,838 | $459 |
| Symbicort | 141 | $63,441 | $450 |
| Incruse Ellipta | 144 | $52,599 | $365 |
| Combivent Respimat | 79 | $41,563 | $526 |
| Flovent Hfa | 99 | $32,763 | $331 |
| Spiriva | 46 | $29,348 | $638 |
| Advair Diskus | 60 | $27,893 | $465 |
| Qvar Redihaler | 73 | $18,680 | $256 |
| Pulmicort Flexhaler | 56 | $18,514 | $331 |
| Arnuity Ellipta | 76 | $17,948 | $236 |
| Ventolin Hfa | 228 | $13,134 | $58 |
| Anoro Ellipta | 24 | $10,163 | $423 |
| Advair Hfa | 14 | $8,149 | $582 |
| Atrovent Hfa | 12 | $7,983 | $665 |
| Flovent Diskus | 18 | $6,625 | $368 |
| Fluticasone-Salmeterol | 27 | $4,313 | $160 |
| Albuterol Sulfate Hfa | 57 | $2,552 | $45 |
| Proair Hfa | 27 | $2,119 | $78 |
| Proair Respiclick | 19 | $1,263 | $66 |
| Prednisone | 100 | $571 | $6 |
| Megestrol Acetate | 11 | $373 | $34 |
| Azithromycin | 12 | $206 | $17 |
| Amoxicillin-Clavulanate Potass | 12 | $103 | $9 |
2018: 27 drugs
| Trelegy Ellipta | 286 | $164,822 | $576 |
| Symbicort | 217 | $77,059 | $355 |
| Breo Ellipta | 186 | $72,138 | $388 |
| Incruse Ellipta | 180 | $61,806 | $343 |
| Spiriva Respimat | 137 | $60,465 | $441 |
| Combivent Respimat | 122 | $50,876 | $417 |
| Advair Diskus | 96 | $45,123 | $470 |
| Spiriva | 54 | $32,182 | $596 |
| Flovent Hfa | 98 | $29,815 | $304 |
| Anoro Ellipta | 44 | $19,156 | $435 |
| Advair Hfa | 29 | $15,479 | $534 |
| Qvar Redihaler | 58 | $14,482 | $250 |
| Ventolin Hfa | 226 | $12,598 | $56 |
| Arnuity Ellipta | 49 | $9,576 | $195 |
| Pulmicort Flexhaler | 39 | $9,186 | $236 |
| Atrovent Hfa | 17 | $7,056 | $415 |
| Qvar | 27 | $6,396 | $237 |
| Flovent Diskus | 18 | $4,260 | $237 |
| Proair Hfa | 48 | $3,805 | $79 |
| Theo-24 | 12 | $2,299 | $192 |
| Prednisone | 99 | $698 | $7 |
| Rifampin | 13 | $655 | $50 |
| Montelukast | 11 | $648 | $59 |
| Ethambutol | 12 | $605 | $50 |
| Azithromycin | 23 | $343 | $15 |
| Amoxicillin-Clavulanate Potass | 22 | $235 | $11 |
| Pantoprazole | 12 | $223 | $19 |
2017: 27 drugs
| Symbicort | 246 | $81,912 | $333 |
| Spiriva Respimat | 176 | $68,283 | $388 |
| Advair Diskus | 150 | $62,935 | $420 |
| Combivent Respimat | 134 | $55,906 | $417 |
| Incruse Ellipta | 115 | $42,537 | $370 |
| Spiriva | 80 | $41,850 | $523 |
| Breo Ellipta | 120 | $41,270 | $344 |
| Flovent Hfa | 68 | $17,075 | $251 |
| Advair Hfa | 34 | $15,865 | $467 |
| Qvar | 60 | $13,010 | $217 |
| Ventolin Hfa | 167 | $9,042 | $54 |
| Atrovent Hfa | 19 | $6,336 | $333 |
| Pulmicort Flexhaler | 24 | $5,223 | $218 |
| Proair Hfa | 47 | $3,488 | $74 |
| Arnuity Ellipta | 12 | $2,518 | $210 |
| Theo-24 | 13 | $2,009 | $155 |
| Ethambutol | 26 | $1,041 | $40 |
| Rifampin | 26 | $927 | $36 |
| Azithromycin | 50 | $776 | $16 |
| Montelukast | 15 | $522 | $35 |
| Prednisone | 83 | $493 | $6 |
| Megestrol Acetate | 13 | $402 | $31 |
| Pantoprazole | 19 | $204 | $11 |
| Promethazine | 26 | $189 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $161 | $12 |
| Fluticasone Propionate | 13 | $150 | $12 |
| Omeprazole | 14 | $119 | $9 |
2016: 24 drugs
| Combivent Respimat | 195 | $71,211 | $365 |
| Symbicort | 232 | $67,828 | $292 |
| Advair Diskus | 172 | $67,149 | $390 |
| Spiriva | 157 | $63,487 | $404 |
| Spiriva Respimat | 75 | $25,660 | $342 |
| Advair Hfa | 41 | $17,702 | $432 |
| Breo Ellipta | 48 | $16,625 | $346 |
| Qvar | 79 | $15,596 | $197 |
| Incruse Ellipta | 44 | $12,351 | $281 |
| Flovent Hfa | 30 | $9,532 | $318 |
| Atrovent Hfa | 23 | $6,900 | $300 |
| Proair Hfa | 91 | $5,549 | $61 |
| Dulera | 19 | $5,144 | $271 |
| Ventolin Hfa | 87 | $4,578 | $53 |
| Anoro Ellipta | 12 | $3,875 | $323 |
| Pulmicort Flexhaler | 16 | $3,127 | $195 |
| Ethambutol | 27 | $1,163 | $43 |
| Rifampin | 28 | $913 | $33 |
| Azithromycin | 46 | $719 | $16 |
| Prednisone | 73 | $465 | $6 |
| Montelukast | 20 | $328 | $16 |
| Pantoprazole | 12 | $134 | $11 |
| Fluconazole | 11 | $90 | $8 |
| Omeprazole | 14 | $55 | $4 |
2015: 20 drugs
| Spiriva | 287 | $102,932 | $359 |
| Combivent Respimat | 248 | $83,595 | $337 |
| Advair Diskus | 223 | $79,793 | $358 |
| Symbicort | 224 | $63,918 | $285 |
| Advair Hfa | 50 | $19,244 | $385 |
| Qvar | 62 | $11,674 | $188 |
| Proair Hfa | 168 | $9,221 | $55 |
| Flovent Hfa | 25 | $6,614 | $265 |
| Dulera | 29 | $6,585 | $227 |
| Anoro Ellipta | 11 | $3,332 | $303 |
| Atrovent Hfa | 12 | $3,190 | $266 |
| Ventolin Hfa | 25 | $1,220 | $49 |
| Azithromycin | 45 | $661 | $15 |
| Prednisone | 92 | $593 | $6 |
| Theophylline Anhydrous | 44 | $584 | $13 |
| Ethambutol | 13 | $493 | $38 |
| Montelukast | 28 | $475 | $17 |
| Rifampin | 11 | $369 | $34 |
| Omeprazole | 22 | $246 | $11 |
| Pantoprazole | 13 | $123 | $9 |
2014: 29 drugs
| Spiriva | 439 | $138,449 | $315 |
| Advair Diskus | 357 | $115,268 | $323 |
| Combivent Respimat | 343 | $108,850 | $317 |
| Symbicort | 236 | $63,938 | $271 |
| Advair Hfa | 57 | $19,580 | $344 |
| Dulera | 41 | $9,578 | $234 |
| Proair Hfa | 155 | $7,983 | $52 |
| Qvar | 39 | $6,765 | $173 |
| Flovent Hfa | 24 | $5,797 | $242 |
| Nasonex | 24 | $4,027 | $168 |
| Atrovent Hfa | 16 | $3,851 | $241 |
| Breo Ellipta | 13 | $3,378 | $260 |
| Ethambutol | 44 | $3,008 | $68 |
| Azithromycin | 76 | $2,242 | $29 |
| Rifampin | 38 | $2,151 | $57 |
| Xopenex Hfa | 13 | $1,332 | $102 |
| Ventolin Hfa | 22 | $1,010 | $46 |
| Theophylline Anhydrous | 94 | $998 | $11 |
| Megestrol Acetate | 27 | $881 | $33 |
| Montelukast | 39 | $880 | $23 |
| Prednisone | 107 | $698 | $7 |
| Nystatin | 16 | $655 | $41 |
| Amox Tr-Potassium Clavulanate | 21 | $491 | $23 |
| Omeprazole | 44 | $357 | $8 |
| Levofloxacin | 19 | $280 | $15 |
| Fluticasone Propionate | 16 | $244 | $15 |
| Pramipexole Dihydrochloride | 13 | $133 | $10 |
| Fluconazole | 11 | $122 | $11 |
| Isoniazid | 12 | $98 | $8 |
2013: 29 drugs
| Advair Diskus | 399 | $117,063 | $293 |
| Spiriva | 252 | $78,466 | $311 |
| Combivent Respimat | 205 | $60,696 | $296 |
| Symbicort | 107 | $27,279 | $255 |
| Combivent | 86 | $20,584 | $239 |
| Advair Hfa | 52 | $16,432 | $316 |
| Atrovent Hfa | 37 | $8,905 | $241 |
| Dulera | 32 | $6,657 | $208 |
| Proair Hfa | 114 | $5,761 | $51 |
| Qvar | 21 | $3,240 | $154 |
| Ethambutol | 43 | $2,723 | $63 |
| Rifampin | 43 | $2,632 | $61 |
| Flovent Hfa | 12 | $2,524 | $210 |
| Theo-24 | 22 | $2,465 | $112 |
| Azithromycin | 74 | $2,079 | $28 |
| Megestrol Acetate | 41 | $1,854 | $45 |
| Clarithromycin | 13 | $1,360 | $105 |
| Theophylline Anhydrous | 74 | $703 | $10 |
| Ventolin Hfa | 16 | $679 | $42 |
| Montelukast | 16 | $541 | $34 |
| Prednisone | 110 | $524 | $5 |
| Fluticasone Propionate | 17 | $513 | $30 |
| Nystatin | 11 | $286 | $26 |
| Omeprazole | 28 | $278 | $10 |
| Levofloxacin | 19 | $260 | $14 |
| Pantoprazole | 15 | $207 | $14 |
| Isoniazid | 28 | $201 | $7 |
| Fluconazole | 11 | $61 | $6 |
| Furosemide | 11 | $32 | $3 |
Money from drug and device companies
$360 in 2025
| 2025 | 9 | 15 | None | $360 |
| 2024 | 1 | 4 | None | $4,144 |
| 2023 | 1 | 16 | $2,000 | $3,391 |
| 2022 | 7 | 45 | None | $8,965 |
| 2021 | 4 | 17 | None | $5,535 |
| 2020 | 1 | 1 | None | $12 |
| 2019 | 8 | 14 | None | $1,059 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Opsumit | $86 | 3 payments
|
| Verona Pharma | Ohtuvayre | $64 | 3 payments
|
| GlaxoSmithKline | Nucala | $41 | 2 payments
|
| Insmed | Arikayce | $39 | 2 payments
|
| Daiichi Sankyo | Enhertu | $29 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $26 | 1 payment
|
See all 15 published payments
| Kite Pharma | Meals · 2025-12-03 | Yescarta | $24 |
| Insmed | Meals · 2025-11-19 | Arikayce | $22 |
| Insmed | Education · 2025-11-18 | Brinsupri | $17 |
| Actelion Pharmaceuticals US | Meals · 2025-10-07 | Opsynvi | $29 |
| Verona Pharma | Meals · 2025-09-09 | Ohtuvayre | $22 |
| Progenics Pharmaceuticals | Meals · 2025-09-03 | Pylarify | $26 |
| Actelion Pharmaceuticals US | Meals · 2025-09-02 | Opsumit | $28 |
| GlaxoSmithKline | Meals · 2025-08-26 | Nucala | $23 |
| Daiichi Sankyo | Meals · 2025-07-23 | Enhertu | $29 |
| Lilly USA | Meals · 2025-07-15 | None | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-09 | Imfinzi | $24 |
| Actelion Pharmaceuticals US | Meals · 2025-04-08 | Opsumit | $30 |
| Verona Pharma | Meals · 2025-04-01 | Ohtuvayre | $17 |
| Verona Pharma | Meals · 2025-01-21 | Ohtuvayre | $25 |
| GlaxoSmithKline | Meals · 2025-01-14 | Nucala | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $4,144
| Intuitive Surgical | Da Vinci Surgical System | $4,144 | 4 payments
|
2023: $3,391
| Intuitive Surgical | Da Vinci Sp | $3,391 | 16 payments
|
2022: $8,965
| Intuitive Surgical | Da Vinci Surgical System | $7,477 | 36 payments
|
| Pulmonx | Zephyr Endobronchial Valve | $1,362 | 4 payments
|
| Janssen Biotech | None | $34 | 1 payment
|
| Eisai | Lenvima | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $23 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $22 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $22 | 1 payment
|
2021: $5,535
| Intuitive Surgical | Da Vinci Surgical System | $4,955 | 11 payments
|
| Ethicon | Monarch Platform | $239 | 3 payments
|
| Medtronic | Illumisite | $203 | 2 payments
|
| Olympus America | Spiration Valve System | $138 | 1 payment
|
2020: $12
| AstraZeneca Pharmaceuticals LP | Breztri Aerosphere | $12 | 1 payment
|
2019: $1,059
| Ethicon | Monarch | $390 | 5 payments
|
| Veran Medical Technologies | Spin | $200 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Tagrisso | $125 | 1 payment
|
| Boston Scientific | Acquire | $123 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $122 | 1 payment
|
| Covidien LP | Superdimension | $54 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $32 | 1 payment
|
| Electromed | Smartvest | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 26.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1225001027
- Licence
- CA A78558California A78558: Current · expires 2027-09-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A785580
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- Po Box 46, Los Altos, CA, 94023
- NPI first listed
- 2006-02-10
- NPI last updated
- 2021-06-28
- NPI record certified
- 2021-06-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2101 Forest Ave, San Jose, CA, 95128